Linagliptin
Showing 201 - 210 of 210
Diabetes, Type 2 Trial (BI 1356 BS, low dose, BI 1356 BS, medium dose, BI 1356 BS, high dose)
Completed
- Diabetes Mellitus, Type 2
- BI 1356 BS, low dose
- +3 more
- (no location specified)
Jul 4, 2014
Healthy Trial (BI 1356 BS)
Completed
- Healthy
- BI 1356 BS
- (no location specified)
Jul 4, 2014
Healthy Trial (BI 1356 BS - single rising dose, BI 1356 BS - multiple rising dose, Placebo)
Completed
- Healthy
- BI 1356 BS - single rising dose
- +2 more
- (no location specified)
Jul 4, 2014
Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 1356 5mg, Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4
Completed
- Diabetes Mellitus, Type 2
- Placebo identical to BI 1356 5mg
- +3 more
-
Tempe, Arizona
- +220 more
Dec 11, 2013
Diabetes, Type 2 Trial in Worldwide (BI 1356, BI 1356 + metformin, Bi 1356 + metformin)
Completed
- Diabetes Mellitus, Type 2
- BI 1356
- +5 more
-
Calgary, Alberta, Canada
- +137 more
Dec 11, 2013
Glucose Metabolism During Hemodialysis
Completed
- ESRD
- Hemodialysis
- +2 more
-
Copenhagen, DenmarkNephrology department, Rigshospitalet
Nov 18, 2013
Type 2 Diabetes Trial in Santiago (drug, procedure, behavioral)
Unknown status
- Type 2 Diabetes
- Best medical treatment
- +5 more
-
Santiago, Región Metropolitana, ChilePontificia Universidad Católica de Chile
Oct 27, 2013
Diabetes Type 2 Trial in Mainz (Linagliptin, Glimepiride)
Unknown status
- Diabetes Mellitus Type 2
- Linagliptin
- Glimepiride
-
Mainz, Rhineland-Palatinate, Germanyikfe GmbH
Apr 10, 2012
Tissue Hypoxia, Hyperlactatemia Trial in Delft, Rotterdam (Early lactate-directed therapy)
Completed
- Tissue Hypoxia
- Hyperlactatemia
- Early lactate-directed therapy
-
Delft, Netherlands
- +4 more
Apr 24, 2008